IMMUNOCYTOCHEMICAL STAINING OF C-ERBB-2 ONCOGENE IN FINE-NEEDLE ASPIRATES OF BREAST-CARCINOMA - A COMPARISON WITH TISSUE-SECTIONS AND OTHER BREAST-CANCER PROGNOSTIC FACTORS

被引:26
作者
CORKILL, ME
KATZ, R
机构
[1] Department of Pathology, University of Colorado Health Sciences Center, Denver, Colorado
[2] M.D. Anderson Cancer Center, University of Texas, Houston, Texas
关键词
BREAST CARCINOMA; BIOPSY; NEEDLE; IMMUNOCYTOCHEMISTRY; ONCOGENE; C-ERBB-2;
D O I
10.1002/dc.2840110311
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The role of fine-needle aspiration (FNA) in breast cancer management is expanding to include prognostic in addition to diagnostic studies. This study was undertaken to compare the immunohistochemical staining of c-erbB-2, a breast cancer prognostic factor, on cytologic FNA smears of breast cancer with that on corresponding formalin-fixed, paraffin-embedded tissue sections of the same tumor and to correlate the c-erbB-2 expression with other known breast cancer prognostic factors. FNA smears (destained, alcohol-fixed, Pap-stained direct smears) and corresponding tissue sections (formalin-fixed, paraffin-embedded, unstained sections) from 36 primary breast carcinomas were stained immunohistochemically with c-erbB-2 antibody using an avidin-biotin procedure. Ten tumors (28%) showed strong positive staining for c-erbB-2 on the FNA smear and, of those ten, seven were positive on the corresponding tissue section and three were negative. In several of the cytology and tissue positive cases, staining on the tissue section was significantly weaker than on the FNA smear, Two cases involved treatment with preoperative chemotherapy; in one of those cases, tissue staining was weaker than cytologic staining, and, in the other case, both were negative. Correlation of c-erbB-2 staining with other prognostic factors showed an association between positive c-erbB-2 staining and high nuclear grade, Our results indicate that immunohistochemical staining for c-erbB-2 can be performed on destained FNA smears of breast carcinomas and may be more sensitive on the cytologic specimens than on formalin-fixed, paraffin-embedded tissue sections. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 28 条
  • [1] Weintraub J, Weintraub D, Mireille R, Vassilakos P., Evaluation of estrogen receptors by immunocytochemistry on fine needle aspiration biopsy specimens from breast tumors, Cancer, 60, pp. 1163-1172, (1987)
  • [2] Marchetti E, Bagni A, Querzoli P, Durante E, Marzola A, Fabris B, Nenci I., Immunocytochemical detection of estrogen receptors by staining with monoclonal antibodies on cytologic specimens of human breast cancer, Acta Cytol, 32, pp. 829-834, (1988)
  • [3] Masood S., Use of monoclonal antibody for assessment of estrogen receptor content in fine‐needle aspiration biopsy specimen from patients with breast cancer, Arch Pathol Lab Med, 113, pp. 26-30, (1989)
  • [4] Skoog L, Humla S, Isaksson S, Tani E., Immunocytochemical analysis of receptors for estrogen and progesterone in fine‐needle aspirates from human breast carcinoma, Diagn Cytopathol, 6, pp. 95-98, (1990)
  • [5] Katz RL, Patel S, Sneige N, Et al., Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinoma, Breast Cancer Res Treat, 15, pp. 191-203, (1990)
  • [6] Lundy J, Lozouski M, Sadri D, Mishriki Y., The use of fine‐needle aspirates of breast cancers to evaluate hormone‐receptor status, Arch Surg, 125, pp. 174-176, (1990)
  • [7] Cajulis R, Sneige N, El-Naggar A., Cytologic nuclear grading of fine needle aspirates of breast carcinoma: concordance with corresponding histologic grading and flow cytometric data, Mod Pathol, 3, (1990)
  • [8] Spyratos F, Brifford M, Gentile A, Brunet M, Brault C, Desplaces A., Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions, Anal Quant Cytol Histol, 9, pp. 485-494, (1987)
  • [9] Levack PA, Mullen P, Anderson TJ, Miller WR, Forrest AP, DNA analysis of breast tumor fine needle aspirates using flow cytometry, Br J Cancer, 56, pp. 643-646, (1987)
  • [10] Remvikos Y, Magdelenat H, Zajdila A., DNA flow cytometry applied to fine needle sampling of human breast cancer, Cancer, 61, pp. 1629-1634, (1988)